Categories
Business

China is beginning scientific trials of a Covid vaccine that may be inhaled

China’s CanSino Biologics will begin clinical trials next week for a Covid-19 vaccine administered by inhalation, the company’s co-founder and chief executive officer Xuefeng Yu told CNBC on Sunday.

The effectiveness rates for China’s Covid vaccines have been found to be lower than those developed by Pfizer-BioNTech and Moderna. Earlier this month, the director of the Chinese Center for Disease Control publicly admitted that Chinese vaccines “don’t have very high protection rates” and that they are considering giving people various Covid shots to make the vaccine more effective.

Yu told CNBC that an inhaled vaccine could be more effective than the injected one because the coronavirus enters the human body through the respiratory tract.

CanSinoBIO is developing the inhalation vaccine together with the Beijing Institute of Biotechnology. The company’s injected adenovirus type 5 vector vaccine – or Ad5-nCoV – has already been approved for use in China and several other countries.

Speaking to CNBC’s Arjun Kharpal at the Boao Forum for Asia in Hainan Province, China, Yu explained that an inhaled vaccine could theoretically provide additional protection by producing antibodies or T cells – white blood cells that are vital to the immune system. activates airways in the EU.

People who received Covid-19 shots at a temporary vaccination site in Kunming, Yunnan Province, China, on April 15, 2021.

Liu Ranyang | China News Service | Getty Images

If that protective layer fails and the virus penetrates deeper into the body, other parts of the immune system could keep fighting the Covid virus, Yu added.

“So you add more layers – makes sense, doesn’t it? That’s why we’re going the mucosal path,” he said.

The CEO said the company used the same concept to develop an inhalation vaccine for tuberculosis, or TB. Studies conducted in Canada showed that the inhaled dose for the TB vaccine needed to protect it “is much, much less than the actual injection,” he said.

Increase the effectiveness of the vaccine

CanSinoBIO’s single-dose injected Covid vaccine has been approved for use in several countries including China, Pakistan, Mexico and Hungary.

The company said preliminary data from third-phase clinical trials overseas showed its vaccine was 68.83% effective at preventing symptomatic Covid-19 disease two weeks after an injection, while the rate after four weeks Fell 65.28%, Reuters reported.

By comparison, updated data showed the Pfizer BioNTech shot was 91% effective at preventing infection, while Moderna said its vaccine was more than 90% effective six months after the second shot.

According to Yu, CanSinoBIO investigated adding a booster shot six months after the first injection, which could improve the immune response to the coronavirus.

“This also suggests that our vaccine could be improved – whether mixed with others or made by ourselves, I think that really requires a scientific study. We actually need data to show which way could be better,” said the CEO.

Reuters reported Monday that Chinese researchers are testing blending Covid vaccines developed by CanSinoBIO and a unit of Chongqing Zhifei Biological Products. The process, which is ongoing in the eastern city of Nanjing, is expected to involve 120 participants, the report said.

China was the first country to report cases of Covid-19 in late 2019 and appears to have largely contained the outbreak. The country has announced that it will vaccinate 40% of its population by June.

Categories
World News

Chile’s coronavirus circumstances hit document ranges regardless of vaccine rollout

A health worker administers a dose of the Pfizer BioNTech vaccine against Covid-19 to a man at Medalla Milagrosa Church in Valparaiso, Chile, on April 6, 2021.

JAVIER TORRES | AFP | Getty Images

LONDON – Chile’s vaccination campaign against the coronavirus has been one of the fastest and most extensive in the world, but a recent surge in infections has raised concern beyond its borders.

Almost 40% of the total population of the South American country have received at least one dose of a Covid-19 vaccine, according to statistics from Our World in Data, reflecting one of the highest vaccination rates in the world.

Only Israel and the UK have vaccinated a greater proportion of their population with at least one dose.

Nonetheless, Chile has seen a sharp increase in coronavirus infections in recent weeks, despite the world-famous vaccine rollout and strict bans affecting a large part of its 19 million residents.

The regional director of the Pan American Health Organization has since emphasized that for most countries in the region, vaccines are insufficient to prevent rising infection rates.

The number of daily cases in Chile rose to a record high on April 9, rising to over 9,000 for the first time since the pandemic began and well above the high of nearly 7,000 last summer.

Health Minister Enrique Paris told reporters on Thursday that he hoped the increase in daily cases has now peaked.

“Once we hit that peak, we don’t expect a decrease, but rather a stabilization and then a return to a smaller number of positive patients,” he said, according to Reuters.

What went wrong?

Health experts say the country’s recent surge in cases is partly due to more virulent strains of the virus, easing public health measures, increased mobility, and defiance of simple precautions like physical distancing and wearing a mask.

The center-right government of Chile, led by President Sebastian Pinera, ordered the country’s borders to be closed from March to November 2020, albeit with a few exceptions, before it was decided at the end of last year to reopen them to international passengers.

Shops, restaurants and some resorts have also opened to help boost the country’s pandemic-hit economy.

Passengers in protective suits against the spread of the novel coronavirus disease are queuing at the counters of Arturo Merino Benitez International Airport in Santiago on April 1, 2021, after Chile announced that it would close its borders in April as COVID-19 rose sharply is cases.

MARTIN BERNETTI | AFP | Getty Images

While the country’s vaccination rollout was ahead of most, the spread of a more virulent strain of the virus – like the P.1 variant first spotted in travelers from Brazil – has resulted in a significant spike in cases.

Given the widespread use of CoronaVac, the coronavirus vaccine manufactured by Chinese company Sinovac, questions about the vaccine’s effectiveness have also been raised.

After the head of the China Center for Disease Control and Prevention stated earlier this month that China may need to replace its Covid vaccines or change the way they are administered to make them sufficiently effective.

“We will solve the problem that current vaccines do not have very high protection rates,” said George Gao, director general of China’s CDC, at a conference on April 11th. He has since told the state media that his comments have been misunderstood.

Late-stage data from China’s Covid vaccines remain unpublished, and the data available from the CoronaVac vaccine varies. Brazilian studies found the vaccine to be just over 50% effective and significantly less effective than Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca, while Turkish researchers reported 83.5% effectiveness.

An ambulance leaves Carlos Van Buren Hospital in Valparaiso, Chile on April 6, 2021, overwhelmed by the large number of Covid-19 positive cases.

JAVIER TORRES | AFP | Getty Images

A study published earlier this month by the University of Chile reported that CoronaVac was 56.5% effective in the country two weeks after giving the second doses. It was also crucial, however, that a dose was only 3% effective.

“This would explain why Chile – with one of the most robust vaccine launches in the world, but 93% of the doses sourced from China – has seen a significant spike in cases and a much slower decline in hospital admissions and deaths compared to the early rollouts in.” Israel, UK and US, “said Ian Bremmer, President of Eurasia Group’s Risk Advisory Group, in a research note.

“Chile and the United Arab Emirates are both considering introducing a third dose (a second booster) of the Chinese vaccine accordingly. A change in communication will make the vaccine more hesitant for Chinese vaccines in general,” said Bremmer.

“Comprehensive Strategies”

“I cannot stress this enough – for most countries, vaccines are not going to stop this wave of the pandemic,” PAHO director Carissa Etienne said during a weekly press conference Wednesday. “There just isn’t enough of it to protect everyone in the most at-risk countries.”

Etienne urged policymakers in the region to implement “comprehensive strategies” to accelerate vaccine adoption and stop transmission through best public health measures.

On April 14, America reported more than 1.3 million Covid infections and nearly 36,000 deaths in the past week, according to the United Nations Health Department.

To date, America has recorded 58.8 million cases and more than 1.4 million deaths, making it the worst-hit region in the world.

“We are not acting like a region in the middle of a worsening outbreak,” said Etienne of PAHO, describing South America as the “epicenter” of the virus.

In addition to easing restrictions in some areas, Etienne said that new and highly communicable variants of the virus had accelerated cases sharply. Currently, Brazil, Colombia, Venezuela, Peru and some areas of Bolivia are seeing a sharp increase in infections.

Paraguay, Uruguay, Argentina and Chile are also seeing sustained increases in Covid cases, Etienne said.

Categories
World News

Fauci Expects Choice on Utilizing Johnson & Johnson Vaccine Friday

A decision to resume administration of Johnson & Johnson’s coronavirus vaccine should be made this Friday when a panel of experts advising the Centers for Disease Control and Prevention says Dr. Anthony S. Fauci, the country’s leading infectious disease expert, is to meet.

“I think we will make a decision by then,” said Dr. Fauci on Sunday on CNN’s State of the Union program.

“I don’t want to be one step ahead of the CDC, the FDA and the Advisory Committee,” he added, but said he expected experts to recommend “some kind of warning or restriction” on using the vaccine.

Federal health officials recommended suspending vaccine injections Tuesday while investigating whether this was related to a rare bleeding disorder. All 50 states except Washington, DC and Puerto Rico have stopped giving the vaccine.

The unusual disorder includes blood clots in the brain combined with low levels of platelets, blood cells that typically promote clotting. The combination, which can lead to coagulation and bleeding at the same time, was initially documented in six women between the ages of 18 and 48 who had received the vaccine one to three weeks earlier. One of the women died and another was hospitalized in critical condition.

This pattern has raised questions about whether vaccinations could be resumed in men or in the elderly. However, with women filling more healthcare positions for which vaccination has been prioritized, it is not clear how the problem could affect men as well. Two more cases of the coagulation disorder were identified on Wednesday, including one in a man who received the vaccine in a clinical trial.

Of the 129.5 million people in the United States who received at least one dose of a Covid-19 vaccine, more than seven million have received Johnson & Johnson’s. If there is a link between the vaccine and the coagulation disorder, the risk remains extremely low, according to experts.

“It is an extremely rare occurrence,” said Dr. Fauci on the ABC program “This Week”. The break should give experts time to gather more information and warn doctors about the clotting disorder so they can make more informed treatment decisions, said Dr. Fauci, who appeared on four television news programs on Sunday morning.

European regulators have investigated similar cases of the unusual coagulation disorder in people who received the AstraZeneca vaccine. Some European countries have now stopped giving this vaccine completely, while others have restricted its use in younger people.

Dr. Fauci also expressed frustration that “a worryingly large segment of Republicans” who have criticized many of the coronavirus restrictions have expressed reluctance to vaccinate. “It’s almost paradoxical,” he said. “On the one hand, they want to be released from the restrictions, on the other hand, they don’t want to be vaccinated. It just makes almost no sense. “

Dr. Fauci said he expects all students to be eligible for a vaccination before school starts in the fall, with younger children being eligible by Q1 2022 at the latest.

Categories
Health

Half of U.S. adults have obtained no less than one Covid vaccine shot

Dr. Jerry Abraham, director of Kedren Vaccines, right, gives Jose Guzman-Wug, 16, a COVID-19 shot while his mother, Adriana Wug, watches at Kedren Health in Los Angeles, CA on Thursday, April 15, 2021.

Allen J. Cockroaches | Los Angeles Times | Getty Images

Half of all adults in the United States have now received at least one dose of Covid-19 vaccine, according to the Centers for Disease Control and Prevention. This is a major milestone in the largest vaccine campaign in the country.

More than 129 million people aged 18 and over received at least one shot, according to the CDC, representing 50.4% of the total adult population. More than 83 million adults, or 32.5% of the total adult population, are fully vaccinated with any of the three US-approved vaccines

The milestone is over 3 million people one day after the global death toll from the virus, according to data from Johns Hopkins University, with global deaths averaging 12,000 per day.

In the US, the rate of new Covid-19 cases every day remains high across the country. The country reports an average of around 68,000 new infections every day. CDC data shows that an average of 3.3 million daily doses of vaccine have been administered over the past week.

Jeff Zients, White House Covid-19 Response Coordinator, said the hiatus in Johnson & Johnson vaccinations, which came after reports of six cases of rare cerebral blood clots, would not slow the vaccination campaign as the country has enough Pfizer and Moderna vaccines disposes.

The Chief Medical Officer of the White House, Dr. Anthony Fauci said Sunday he thinks the U.S. will likely resume use of the Johnson & Johnson vaccine with a warning or restriction, and expects a decision to be made once the CDC’s vaccine advisory panel meets on Friday to discuss the resumption.

“I guess we will continue to use it in some form,” Fauci said during an interview on NBC’s Meet the Press. “I very seriously doubt they’ll just cancel it. I don’t think that’s going to happen.”

Categories
Business

U.S. will seemingly resume use of J&J Covid vaccine with a warning

Dr. Anthony Fauci, director of the National Institute for Allergies and Infectious Diseases, testifies on April 15, 2021 at the House Select subcommittee on the coronavirus crisis on Capitol Hill in Washington.

Susan Walsh | Pool | Reuters

The Chief Medical Officer of the White House, Dr. Anthony Fauci said Sunday he believes the US is likely to resume use of the Johnson & Johnson Covid-19 vaccine with a warning or restriction.

Health officials on Tuesday urged states to temporarily suspend the single dose of J&J after six cases of rare brain blood clots were reported in women of approximately 7 million people who received the vaccine in the United States

The cases occurred in women ages 18 to 48 who developed symptoms six to 13 days after receiving the shot. The Food and Drug Administration said the recommendation to stop the vaccine was “out of caution”.

Fauci said he expected a decision on the J&J vaccine as early as Friday when the vaccine advisory panel of the U.S. Centers for Disease Control and Prevention meets to discuss reopening.

“I guess we will continue to use it in some form,” Fauci said during an interview on NBC’s Meet the Press. “I very seriously doubt they’ll just cancel it. I don’t think that’s going to happen. I think there will likely be some kind of warning or restriction or risk assessment.”

“I don’t think it will just go back and say, ‘Okay, everything is fine. Go right back.’ I think it will likely say, “Okay, we’re going to use it, but be careful in these certain circumstances,” Fauci continued.

About 5% of vaccine supplies in the US are lost due to the pause in J&J admission. It is unclear how the hiatus will affect the company’s goal of delivering 100 million cans nationwide by the end of May.

White House Tsar Jeff Zients said the stop would have no material impact on the U.S. vaccination program, which is handing out enough Pfizer and Moderna vaccines to continue the current pace of around 3 million shots a day.

The country reports an average of 3.3 million daily vaccine doses given in the past week, and 3 million if only Pfizer and Moderna are counted. According to CDC data, only around 7.8 million of the total of 202 million recordings in the US are from J&J

“You don’t want to jump in front of yourself and decide that you know the full spectrum. This is one of the reasons they paused and hopefully we’ll know by Friday,” Fauci said during an interview on CBS. “Face the nation.”

– CNBC’s Nate Rattner contributed to the coverage

Categories
Business

J&J vaccine pause may make it tougher for some teams to get a shot

A homeless man wearing gloves and a protective mask sits with a sign that reads “Seeking Human Kindness” amid the coronavirus pandemic on April 19, 2020 in New York City, United States.

Alexi Rosenfeld | Getty Images Entertainment | Getty Images

The Johnson & Johnson Covid vaccination break It may not slow the overall pace of US vaccine adoption much, but it will make it harder for hard-to-reach populations to get a chance.

In response to the Food and Drug Administration’s request on Tuesday that states temporarily suspend use of the J&J vaccine “out of caution” after six women developed a bleeding disorder, White House Tsar Covid Jeff Zients said the Announcement would have no impact on the US vaccination program.

“We have more than enough supplies of Pfizer and Moderna vaccines to continue the current pace of around 3 million shots a day,” Zients told reporters at a news conference.

So far, this has been the case. The country reports an average of 3.3 million daily vaccine doses given in the past week, and 3 million if only Pfizer and Moderna are counted. Only about 7.8 million of the total of 202 million recordings in the US are from J&J, according to data from the Centers for Disease Control and Prevention.

However, Johnson & Johnson’s single-shot vaccine makes up about 10% of all fully vaccinated people in the United States, a percentage that has been on the rise for weeks, and it has proven valuable in certain situations and communities.

“Because of the nature of the J&J vaccine, it is often used for specific circumstances and populations who have been more difficult to obtain vaccines for,” said Josh Michaud, associate director of global health at Kaiser Family Foundation.

Bulky vaccination centers and mobile vans that deliver doses to be administered on the go are likely to have an easier time with Johnson & Johnson’s storage requirements, Michaud said. This vaccine only needs to be kept in a standard refrigerator, while the requirements for Pfizer and Moderna are stricter.

And for certain population groups, such as B. Administering a two-dose regimen can be challenging for prisoners moving to another facility or homeless people who are not permanent residents. Many states have used the J&J vaccine on these groups because Michaud says it is difficult to find people to give a second dose.

The one-shot option may also be more appealing to those who are more reluctant to get a vaccine. A survey by the Kaiser Family Foundation in March found that among those who say they’d like to wait and see how the vaccines work before being self-vaccinated, a greater proportion took the J&J single-dose vaccine compared to either dose option would receive.

One in six people in the “wait and see” group said they would “definitely get” the J&J vaccine, while roughly one in ten said the same thing about the Pfizer or Moderna vaccines.

“We know there is a significant section of the people on the fence who are concerned with vaccines in general,” said Michaud. “And I think the J&J vaccine is actually a plus for this group. It’s a big selling point for people on the fence.”

Add all of these factors together and the J&J hiatus could “have a major negative impact on US vaccination rates,” he said.

It is not yet clear how long it will take to end the Johnson & Johnson vaccine. The Chief Medical Officer of the White House, Dr. Anthony Fauci said the break could last anywhere from a few days to a few weeks.

Vaccinate homeless people

Shelly Nortz, assistant executive director of politics at New York City-based advocacy group Coalition for the Homeless, said Johnson & Johnson’s vaccination break will make it harder to get pictures of the populations she works with.

The coronavirus has hit the homeless in New York hard, especially in community housing. An analysis by the Coalition for the Homeless and New York University found that the age-adjusted mortality rate for homeless homeless New Yorkers was 49% higher than the citywide rate as of February.

And while the New York homeless vaccination campaign is off to a solid start – Nortz said the city’s latest announcement showed about 4,500 fully vaccinated single homeless adults out of a total of 21,000, a pace not far below the nationwide rate – the J & J-stop will be a hurdle.

“Everyone was very excited about the unique situation with J & J,” she said, “especially for people who are unprotected and therefore not predictably in the same place.”

The Coalition for the Homeless recently partnered with the Center for Urban Community Services, which provides mobile medical care across New York, to deliver the Johnson & Johnson vaccine to one of its emergency food locations. This program is now on hold, as are discussions about offering the J&J vaccine at the group’s headquarters, where many customers come to collect their mail.

Dr. Van Yu, chief medical officer at CUCS, agrees that a Pfizer or Moderna two-dose schedule makes things a lot more complicated.

“If you live outside, how will I find you in four weeks?” he said.

Yu said the protection system can make it easier to keep track of people, but there’s still a lot of churn as people come and go or are assigned to one of the hundreds of protected areas in New York City.

Nortz said the ease of keeping the J&J recordings is another benefit of vaccinating the homeless.

“The fact that the other two approved vaccines require freezer storage in one case makes it very difficult to do anything mobile or pop-up or with an unknown number of people,” she said.

Zients announced Tuesday that all vaccine delivery channels, including mobile delivery units, are equipped to deliver all three vaccines. Yu said the Moderna vaccine was easy to use in his group’s mobile locations, but due to the extremely cold refrigeration requirements of the Pfizer vaccine, it wasn’t an option.

He currently sits on 185 unused J&J doses and has no access to Moderna vaccines.

Some homeless people in the South Bronx, where Noel Concepcion works as the adult homeless service director for the nonprofit group BronxWorks, have preferred the J&J vaccine because only one dose is required. However, the hiatus and associated misinformation makes it harder to tell a group already skeptical of the government the importance of vaccination, Concepcion said, and this could lead to some reluctance to all three vaccine options.

According to Concepcion, BronxWorks had to cancel a vaccination event in order to take advantage of the existing range of J&J recordings due to the break.

J&J is more convenient for many working professionals

Other barriers to getting a Covid vaccine, such as an inflexible work schedule or responsibility for childcare, have made Johnson & Johnson’s single vaccine an essential option for some.

Liz Schwandt, who leads a volunteer group called Get Out the Shot designed to help people book vaccination appointments in Los Angeles, said many of the callers on her team’s hotline don’t have traditional work benefits or protections like work interruptions. Many of them are domestic servants such as house cleaners, private nannies or gardeners who are paid in cash from the books. Some are employees who don’t have a 9-to-5 job, like the group of night shift administrators that Get Out the Shot recently booked appointments for.

Elizabeth Raygoza receives her Pfizer vaccine from nurse-certified Alyssa Hernandez on March 17, 2021 when the City of Vernon Health Department staff used the city’s new mobile health unit clinic to help nearly 250 food processing workers at COVID-19 To give vaccinations Rose & Shore, a major local convenience food manufacturer serving supermarkets, schools, restaurants, airlines and others.

Al Seib | Los Angeles Times | Getty Images

“We hear stories all the time like hey, my employer lets me get the vaccine but doesn’t give me any free time,” she said, adding, “for a working family that misses a four-hour shift [for a vaccination appointment] can be a huge loss of wages. ”

According to Schwandt, the responsibility for childcare and the dependence on public transport make it difficult to attend multiple appointments.

While Get Out the Shot is booking appointments for all three vaccines, Schwandt said the FDA’s first approval of the J&J vaccine in February was welcome news.

“We were so excited,” she said. “We loved having the one and done option for people.”

A CDC panel on Wednesday postponed a decision on Johnson & Johnson’s Covid vaccine while investigations into the bleeding disorder continue. The panel is expected to meet again next week and decide what to recommend to the CDC.

Categories
Health

Ladies and the Covid-19 Vaccine: What You Have to Know

A study by the Centers for Disease Control and Prevention published in February looked at the Pfizer-BioNTech and Moderna vaccines and found that 79 percent of the side effects reported to the agency were from women, although only 61 percent of the vaccines were administered to women.

Women could be more likely to report side effects than men, said Dr. Sabra L. Klein, Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. Or, she added, women may experience side effects to a greater extent. “We’re not sure what it is,” she said.

If women actually experience more side effects than men, there may be a biological explanation: women and girls can make up to twice as many antibodies after flu shots and vaccines for measles, mumps, and rubella (MMR), and hepatitis A and B, probably due to a mixture of factors including reproductive hormones and genetic differences.

One study found that women accounted for 80 percent of all adult allergic reactions to vaccines in nearly three decades. Similarly, the CDC reported that most anaphylactic reactions to Covid-19 vaccines, although rare, occurred in women.

In a letter published in the New England Journal of Medicine describing people’s experiences with redness, itching, and swelling that began four to eleven days after the first shot of the Moderna vaccine, 10 of the 12 patients were women. However, it’s not clear if women are more prone to the problem.

If you have mild side effects like a headache or low fever, this is a good thing, said Dr. Small as it means your immune system is going up. However, a lack of side effects doesn’t mean the vaccine isn’t working.

You can share your symptoms or concerns through the CDC’s V-Safe app, which records symptoms and provides post-vaccination health check-ins. Medically important reports sent with V-safe are followed by a call from a representative.

Categories
Health

Why the Vaccine Security Numbers Are Nonetheless Fuzzy

“I will often say that the risk of getting a blood clot with birth control pills is similar to having a serious reaction to penicillin,” said Dr. Raegan McDonald-Mosley, a gynecologist and the CEO of Power to Decide, a group dedicated to reducing unwanted pregnancies. She often discusses the risk of blood clots with her patients, explaining the increase in risk and the overall size of that risk. Most patients, she said, choose their birth control method based on other considerations.

What You Need To Know About The Johnson & Johnson Vaccine Break In The United States

    • On April 13, 2021, U.S. health officials called for an immediate halt to use of Johnson & Johnson’s single-dose Covid-19 vaccine after six recipients in the U.S. developed a rare blood clot disorder within one to three weeks of vaccination.
    • All 50 states, Washington, DC, and Puerto Rico have temporarily suspended use of the vaccine or suspended from recommended vendors. The U.S. military, government-run vaccination centers, and a variety of private companies, including CVS, Walgreens, Rite Aid, Walmart, and Publix, also paused the injections.
    • Fewer than one in a million Johnson & Johnson vaccinations are currently being studied. If there is indeed a risk of blood clots from the vaccine – which has yet to be determined – the risk is extremely small. The risk of contracting Covid-19 in the United States is much higher.
    • The hiatus could complicate the country’s vaccination efforts at a time when many states are facing spikes in new cases and are trying to address vaccine hesitation.
    • Johnson & Johnson has also decided to delay the launch of its vaccine in Europe amid concerns about rare blood clots, which is taking another blow to the vaccine surge in Europe. South Africa, devastated by a contagious variant of the virus found there, also stopped using the vaccine. Australia announced that it would not buy cans.

Penicillin, a widely used antibiotic, causes serious allergic reactions in 10,000 to 10,000 patients.

For vaccines, however The safety threshold is generally higher than with other types of medication. As many researchers have found, Covid-19 also carries the risk of serious blood clots – much more than any plausible estimate of the vaccine’s effectiveness. But not everyone who doesn’t get vaccinated gets sick.

“The disease you happen to get and the vaccine you choose to get and that makes it harder,” said Dr. Steven Black, Professor Emeritus of Pediatrics at Cincinnati Children’s Hospital studying vaccine safety.

Other vaccines are much less likely to have serious adverse events than birth control pills or penicillin – they generally affect less than 1 in 100,000 people who receive a given vaccine. That rate is “clearly much, much lower than what is tolerated for a drug,” said Dr. Nicola Klein, director of the Kaiser Permanente vaccine study center involved in the Vaccine Safety Datalink study.

Most other vaccines protect against diseases that are rather rare. In contrast, Covid-19 is still widespread in the United States and many parts of the world. Given the severity of the disease and how easily it spreads, the value of vaccination may now be greater than if such compromises are normally considered.

Categories
Health

Pfizer CEO says third Covid vaccine dose doubtless wanted inside 12 months

President Joe Biden listens as Pfizer CEO Albert Bourla speaks at the Pfizer Kalamazoo manufacturing facility in Portage, Michigan on February 19, 2021.

Brendan Smialowski | AFP | Getty Images

Albert Bourla, CEO of Pfizer, said people “likely” will need a booster dose of a Covid-19 vaccine within 12 months of being fully vaccinated. His comments were posted on Thursday but recorded on April 1st.

Bourla said it was possible that people would need to be vaccinated against the coronavirus annually.

“A likely scenario is that a third dose is likely to be needed, somewhere between six and twelve months, and there will be an annual revaccination from there, but all of this needs to be confirmed. And again the variants will play a key role,” said he Bertha Coombs of CNBC during an event with CVS Health.

“It is extremely important to suppress the pool of people who may be susceptible to the virus,” Bourla said.

The comment comes after Johnson & Johnson CEO Alex Gorsky told CNBC in February that people may need to be vaccinated against Covid-19 annually, just like seasonal flu shots.

Researchers still don’t know how long protection against the virus will last once someone has been fully vaccinated.

Pfizer said earlier this month that up to six months after the second dose, its Covid-19 vaccine was more than 91% effective against the coronavirus and more than 95% effective against serious illnesses. Moderna’s vaccine, which uses technology similar to Pfizer, was also shown to be highly effective after six months.

Pfizer’s data was based on more than 12,000 vaccinated participants. However, researchers say more data is needed to determine if protection continues after six months.

David Kessler, the Biden government’s chief science officer for Covid Response, said earlier Thursday that Americans should expect booster vaccinations to protect against coronavirus variants.

Kessler told US lawmakers that currently approved vaccines offer high levels of protection, but that new variants may “question” the effectiveness of the shots.

“We don’t know everything right now,” he told the House Select subcommittee on the coronavirus crisis.

“We are investigating the durability of the antibody response,” he said. “It seems strong, but it’s wearing off a bit and no doubt the variants are challenging … they make these vaccines work harder. So I think we should, for planning purposes, for planning purposes only, expect us to possibly need to increase. “”

In February, Pfizer and BioNTech announced that they were testing a third dose of their Covid-19 vaccine to better understand the immune response against new variants of the virus.

At the end of last month, the National Institutes of Health began testing a new Covid vaccine from Moderna, in addition to the existing one, which is intended to protect against a problematic variant first found in South Africa.

Moderna CEO Stephane Bancel told CNBC on Wednesday that the company is hoping to have a booster shot for its two-dose vaccine in the fall.

Categories
Health

Can the Covid Vaccine Shield Me Towards Virus Variants?

The main concern of B.1.1.7 is that it is highly contagious and that it is spreading rapidly among the unvaccinated, potentially overwhelming hospitals in areas where cases are soaring.

All of the main vaccines used – Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca, Sputnik, and Novavax – have been shown to be effective against B.1.1.7. We know this from a large number of studies and indicators. First, scientists used the blood of vaccinated patients to study how well vaccine antibodies bind to a variant in a test tube. The vaccines have all proven themselves relatively well against B.1.1.7. There is also data from clinical trials, notably from Johnson & Johnson and AstraZeneca (the most widely used vaccine in the world), showing that it is effective against both infections and severe ones in areas where B.1.1.7 is circulating Diseases are highly effective. And in Israel, for example, where 80 percent of the eligible population are vaccinated (all with the Pfizer shot), even as schools, restaurants, and workplaces open, case numbers drop, suggesting vaccines may introduce new infections, including those , curb caused by variants.

No vaccine is child’s play, and although the Covid vaccines offer a high level of protection, people who have been vaccinated sometimes still get infected. But breakthrough cases from vaccinated people are very rare, even when variants trigger an increase in the number of cases. And the vaccines clearly prevent serious illness and hospitalization in the few vaccinated patients who become infected.

What is the risk of infection after vaccination? Nobody really knows, but we have some pointers. For example, during the Moderna study, only 11 out of 15,210 vaccinated patients were infected. Both Pfizer and Moderna are currently conducting more detailed studies of breakthrough cases in vaccinated subjects and should publish these data soon.

Updated

April 15, 2021, 9:08 p.m. ET

Two real-world studies of vaccinated health care workers at much higher risk of virus exposure than the rest of us offer hopeful signs. One study found that only four out of 8,121 fully vaccinated employees at the University of Texas’ Southwestern Medical Center in Dallas were infected. The other found that only seven of 14,990 employees at UC San Diego Health and the David Geffen School of Medicine at the University of California at Los Angeles tested positive two or more weeks after receiving a second dose of Pfizer-BioNTech or Moderna vaccinations . Both reports were published in the New England Journal of Medicine and are a sign that breakthrough cases were uncommon even in those who were frequently exposed to sick patients, although cases in the United States rose sharply. Most importantly, patients infected after vaccination had mild symptoms. Some people had no symptoms at all and were only discovered through tests in studies or as part of their independent medical care.

Researchers are still investigating whether the variants may increase the number of breakthrough cases or whether vaccine antibodies decline over time. So far, data from Moderna shows that the vaccine is still 90 percent effective after at least six months. Pfizer has reported similar results.

A recent study of 149 people in Israel who became infected with the Pfizer vaccine after vaccination found that a variant first identified in South Africa was more likely to cause breakthrough infections. However, these eight infections occurred between the seventh and the 13th day after the second dose. “We didn’t see a South African variant 14 days after the second dose,” said Adi Stern, the study’s lead author, professor at the Shmunis School of Biomedicine and Cancer Research at Tel Aviv University. “It was a small sample size, but it is very likely that two weeks after the second dose the level of protection may increase and the South African variant will be blocked completely. That gives us more room for optimism. “